Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

Market Cap	15.40B
Revenue (ttm)	1.45B
Net Income (ttm)	223.76M
Shares Out	583.16M
EPS (ttm)	0.38
PE Ratio	64.32
Forward PE	44.84
Dividend	0.31 (1.16%)
Ex-Dividend Date	Dec 5, 2023

Volume	279,372
Open	26.52
Previous Close	26.70
Day's Range	26.37 - 26.67
52-Week Range	18.58 - 26.70
Beta	0.39
Analysts	n/a
Price Target	22.64 (-14.14%)
Earnings Date	May 28, 2024

About FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as res...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Country: New Zealand
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In 2022, FPH's revenue was 1.49 billion, a decrease of -2.26% compared to the previous year's 1.52 billion. Earnings were 250.30 million, a decrease of -33.59%.

Financial numbers in NZD